Zinc, but not paracetamol, prevents depressive-like behavior and sickness behavior, and inhibits interferon-gamma and astrogliosis in rats

References

Page 1

	Year	Citations
Twenty years of research on cytokine-induced sickness behavior Robert Dantzer, Keith W. Kelley Brain Behavior and Immunity InflammationCytokinePsychoneuroimmunologyCytokine-induced Sickness BehaviorAutoimmune Disease	2006	1.4K
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice Jason C. O’Connor, Mark A. Lawson, Caroline André, Molecular Psychiatry Indoleamine 2,3-Dioxygenase ActivationPsychiatryBiochemistryLipopolysaccharide-induced Depressive-like BehaviorMedicine	2008	1.3K
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial Stephen K. Tyring, Alice B. Gottlieb, Kim Papp, The Lancet PsychiatryMedicineClinical TrialsDepressionClinical Dermatology	2005	1.1K
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Norbert Müller, Markus Schwarz, Sandra Dehning, Molecular Psychiatry PsychiatryAdd-on Pilot StudyPsychotropic MedicationSubcortical Ischemic DepressionPharmacology	2006	789
Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J.M. Bourre PubMed	2007	618
Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Depression and Anxiety	2009	392
Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion Michaël Maes Neuropsychopharmacology InflammationInterleukin-10 SecretionCytokinePsychoneuroimmunologyAntidepressants Inhibition	1999	357
Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Michaël Maes, Eric Vandoolaeghe, Hugo Neels, Biological Psychiatry InflammationPsychoneuroimmunologyPsychiatryMood SymptomMedicine	1997	273
The impact of major depressive disorder on the short‐ and long‐term outcome of Crohn's disease treatment with infliximab Philippe Persoons, Séverine Vermeire, Koen Demyttenaere, Alimentary Pharmacology & Therapeutics	2005	254
Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Gabriel Nowak, Marcin Siwek, Dominika Dudek, PubMed Antidepressant TherapyPsychotropic MedicationPsychopharmacologyPharmacotherapyMental Health	2004	238

Page 1